体功能化氧化铁纳米粒子用于癌症治疗:向策略,机制和转化机会
Andrey N Kuskov1, Lydia-Nefeli Thrapsanioti2, Ekaterina Kukovyakina1
1Department of Chemical-Pharmaceutical and Cosmetic Products Technology, D. Mendeleev University of Chemical Technology of Russia, 125047 Moscow, Russia.
Molecules (Basel, Switzerland)
|January 28, 2026
概括
酸铁氧化物纳米粒子 (IONP) 结合剂通过改善药物输送和向来增强癌症治疗. 这些混合体提供精确的瘤治疗,具有对挑战性瘤的成像和治疗能力.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 治疗性体在瘤学中表现有前途,但面临着稳定性和生物分布不佳等挑战.
- 氧化铁纳米颗粒 (IONPs) 是适用于药物输送和成像的生物兼容性磁性纳米材料.
研究的目的:
- 探索将类与IONP集成到晚期癌症治疗的潜力.
- 克服传统类疗法在瘤学中的局限性.
主要方法:
- 功能化IONP与酸用于向的交付和增强瘤透.
- 利用IONP来控制药物释放,MRI跟踪和磁热过热.
- 研究-IONP杂交物对瘤微环境 (TME) 的影响.
主要成果:
- 酸-IONP结合体表明选择性瘤向和改善组织透.
- IONP促进受控分娩,使基于MRI的监测成为可能,并激活治疗机制.
- 这些混合物调节TME,增强药物可访问性和克服耐药性.
- IONP的铁驱动化学可以诱导铁和自,这对于耐火性瘤至关重要.
结论:
- -IONP合体代表了一种用于精密癌症纳米医学的新型混合系统类.
- 这些治疗药物结合了准特异性,成像和治疗多功能性.
- 体工程和纳米技术的进步加速了这些结合物的转化潜力,用于下一代癌症治疗.
相关概念视频
Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
Mechanical Protein Functions
5.6K
Proteins perform many mechanical functions in a cell. These proteins can be classified into two general categories- proteins that generate mechanical forces and proteins that are subjected to mechanical forces. Proteins providing mechanical support to the structure of the cell, such as keratin, are subjected to mechanical force, whereas proteins involved in cell movement and transport of molecules across cell membranes, such as an ion pump, are examples of generating mechanical force.
5.6K
Cancer Therapies
10.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.1K
Translation
156.2K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
156.2K
Mechanical Protein Function
2.5K
2.5K
Initiation of Translation
38.9K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
38.9K


